Market Tracker

08/30 5:16pm ET

TherapeuticsMD Inc (NYSE MKT LLC:TXMD)

6.88
Delayed Data
As of 4:00pm ET
 +0.15 / +2.23%
Today’s Change
5.18
Today|||52-Week Range
11.26
-33.65%
Year-to-Date
No recent news for TherapeuticsMD Inc.

Today’s Trading

Previous close6.73
Today’s open6.80
Day’s range6.76 - 7.32
Volume1,420,823
Average volume (3 months)1,231,025
Market cap$1.3B
Dividend yield--
Data as of 4:00pm ET, 08/30/2016

Growth & Valuation

Earnings growth (last year)-36.11%
Earnings growth (this year)+12.65%
Earnings growth (next 5 years)+26.00%
Revenue growth (last year)+34.05%
P/E ratioNM
Price/Sales89.15
Price/Book18.99

Competitors

 Today’s
change
Today’s
% change
SRPTSarepta Therapeutics...-0.19-0.69%
TBPHTheravance Biopharma...-0.45-1.56%
CBMCambrex Corp+0.19+0.44%
LCILannett Company Inc-0.62-1.83%
Data as of 4:02pm ET, 08/30/2016

Financials

Next reporting dateNovember 2, 2016
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$20.1M
Annual profit (last year)-$85.1M
Net profit margin-422.37%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Director
Robert G. Finizio
President &
Director
John C. K. Milligan
Corporate headquarters
Boca Raton, Florida

Forecasts